RFK Jr. Unveils $144M Plan Against Microplastics

Robert F Kennedy JR in suit indoors. — HUGE PLAN AGAINST MICROPLASTICS

Microplastics invade every human placenta tested, prompting HHS Secretary Robert F. Kennedy Jr. to launch a $144 million federal program amid growing fears of unseen health threats from everyday plastics.

Story Highlights

HHS’s STOMP program allocates $144 million to measure, understand, and remove microplastics from human bodies, prioritizing pregnant people, children, and workers.
RFK Jr. and EPA Administrator Lee Zeldin announced the initiative, coinciding with microplastics added to EPA’s Contaminant Candidate List for the first time.
Microplastics detected in blood, lungs, brains, livers, kidneys—linked in animal studies to diseases like cancer and depression-like symptoms.
Proposals due May 6 and June 22, 2026, with CDC validating tools for widespread clinical use.

Program Launch Details

HHS, through ARPA-H, initiated the STOMP program, officially “Systemic Targeting of MicroPlastics.” This $144 million effort develops standardized tools to detect and quantify microplastics in human organs.

Secretary Robert F. Kennedy Jr. announced it last Thursday, emphasizing measurable buildup in blood, lungs, livers, kidneys, and placentas. The program targets vulnerable groups, including pregnant individuals, children, and high-exposure workers, facing risks from food, water, and air.

Health Risks and Scientific Gaps

Microplastics, particles smaller than 5mm, are present in every tested human placenta and correlate with gut microbiome changes resembling those associated with depression and colorectal cancer. Animal studies show that low-dose nanoplastics alter gut and liver function, leading to disease.

Human data confirms presence but lacks organ-specific measurement tools and type-specific harm details. STOMP addresses these gaps with Phase 1 focusing on detection and mechanisms, and Phase 2 on removal strategies.

Experts note that no precise measurement methods exist, as each plastic type affects biology differently. ARPA-H seeks multidisciplinary teams of toxicologists and data scientists. CDC will independently validate tools for reliable, scalable clinical tests that cost under $50 and take less than 15 minutes.

The Department of Health and Human Services is introducing a first-of-its-kind program to study microplastics and the effect they have on the human body, HHS Secretary Robert F. Kennedy Jr. announced.https://t.co/MBFsgKN3tv

— WJZ | CBS Baltimore (@wjz) April 2, 2026

EPA Coordination and Timeline

EPA Administrator Lee Zeldin simultaneously added microplastics to the draft Contaminant Candidate List (CCL 6), opening a 60-day public comment period.

This first-ever step prioritizes research on drinking water contaminants alongside pharmaceuticals and PFAS. The joint HHS-EPA actions respond to public concerns about tap water contamination, pledging gold-standard science rather than speculation.

Solution summaries for STOMP are due May 6, 2026, with full proposals by June 22. Kennedy stated, “We are dealing with a measurable, growing presence inside the human body,” underscoring urgency.

This aligns with President Trump’s Make America Healthy Again goals, filling the void left by prior environmental monitoring that focused solely on ecosystems rather than human health.

Implications for Americans

Short-term, validated tests enable monitoring and interventions for at-risk communities. Long-term, findings could drive regulations that reduce exposure through water treatment and changes in the plastics industry.

The $144 million spurs biotech innovation, addressing public anxiety over invisible toxins eroding health and the American Dream of vitality through hard work.

Both conservatives frustrated by regulatory overreach and liberals wary of industry pollution share concerns over federal inaction on elite-protected threats like microplastics. This program signals accountability, protecting families from deep state neglect of tangible dangers in daily life.